Annual Current Assets
$7.33 M
-$5.83 M-44.31%
31 December 2023
Summary:
Monopar Therapeutics annual total current assets is currently $7.33 million, with the most recent change of -$5.83 million (-44.31%) on 31 December 2023. During the last 3 years, it has fallen by -$9.47 million (-56.35%). MNPR annual current assets is now -64.27% below its all-time high of $20.52 million, reached on 31 December 2021.MNPR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$6.07 M
-$1.11 M-15.46%
30 September 2024
Summary:
Monopar Therapeutics quarterly total current assets is currently $6.07 million, with the most recent change of -$1.11 million (-15.46%) on 30 September 2024. Over the past year, it has dropped by -$2.50 million (-29.16%). MNPR quarterly current assets is now -76.51% below its all-time high of $25.84 million, reached on 31 March 2021.MNPR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -44.3% | -29.2% |
3 y3 years | -56.4% | -73.0% |
5 y5 years | +1.1% | +18.8% |
MNPR Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -64.3% | at low | -73.0% | at low |
5 y | 5 years | -64.3% | +1.1% | -76.5% | +18.8% |
alltime | all time | -64.3% | +250.0% | -76.5% | +18.8% |
Monopar Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $6.07 M(-15.5%) |
June 2024 | - | $7.18 M(-19.4%) |
Mar 2024 | - | $8.91 M(+21.5%) |
Dec 2023 | $12.60 K(-79.4%) | $7.33 M(-14.4%) |
Sept 2023 | - | $8.57 M(-16.8%) |
June 2023 | - | $10.30 M(-12.6%) |
Mar 2023 | - | $11.78 M(-10.5%) |
Dec 2022 | $61.20 K(>+9900.0%) | $13.17 M(-8.4%) |
Sept 2022 | - | $14.37 M(-13.7%) |
June 2022 | - | $16.65 M(-7.6%) |
Mar 2022 | - | $18.01 M(-12.2%) |
Dec 2021 | $0.00 | $20.52 M(-8.6%) |
Sept 2021 | - | $22.45 M(-8.0%) |
June 2021 | - | $24.39 M(-5.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $25.84 M(+53.8%) |
Dec 2020 | $68.90 K(-43.7%) | $16.80 M(-7.1%) |
Sept 2020 | - | $18.09 M(+42.1%) |
June 2020 | - | $12.73 M(+0.1%) |
Mar 2020 | - | $12.72 M(-3.9%) |
Dec 2019 | $122.40 K(+86.3%) | $13.23 M(+159.0%) |
Sept 2019 | - | $5.11 M(-8.7%) |
June 2019 | - | $5.60 M(-11.9%) |
Mar 2019 | - | $6.35 M(-12.4%) |
Dec 2018 | $65.70 K(-91.8%) | $7.25 M(-8.1%) |
Sept 2018 | - | $7.89 M(+3.2%) |
June 2018 | - | $7.65 M(-8.4%) |
Mar 2018 | - | $8.35 M(-8.6%) |
Dec 2017 | $800.00 K(-0.0%) | $9.13 M |
Dec 2016 | $800.40 K | - |
FAQ
- What is Monopar Therapeutics annual total current assets?
- What is the all time high annual current assets for Monopar Therapeutics?
- What is Monopar Therapeutics annual current assets year-on-year change?
- What is Monopar Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly current assets year-on-year change?
What is Monopar Therapeutics annual total current assets?
The current annual current assets of MNPR is $7.33 M
What is the all time high annual current assets for Monopar Therapeutics?
Monopar Therapeutics all-time high annual total current assets is $20.52 M
What is Monopar Therapeutics annual current assets year-on-year change?
Over the past year, MNPR annual total current assets has changed by -$5.83 M (-44.31%)
What is Monopar Therapeutics quarterly total current assets?
The current quarterly current assets of MNPR is $6.07 M
What is the all time high quarterly current assets for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly total current assets is $25.84 M
What is Monopar Therapeutics quarterly current assets year-on-year change?
Over the past year, MNPR quarterly total current assets has changed by -$2.50 M (-29.16%)